Insider Transactions in Q1 2019 at Johnson & Johnson (JNJ)
Insider Transaction List (Q1 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2019
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Bona fide gift
|
Direct |
736
-0.55%
|
-
|
|
Feb 11
2019
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
11,435
-9.07%
|
$1,497,985
$131.94 P/Share
|
|
Feb 11
2019
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
3,710
+2.86%
|
-
|
|
Feb 11
2019
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
22,624
+15.6%
|
-
|
|
Feb 11
2019
|
Alex Gorsky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
37,374
-8.76%
|
$4,895,994
$131.94 P/Share
|
|
Feb 11
2019
|
Alex Gorsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,127
+2.76%
|
-
|
|
Feb 11
2019
|
Alex Gorsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
73,947
+15.13%
|
-
|
|
Feb 11
2019
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Payment of exercise price or tax liability
|
Direct |
3,578
-15.53%
|
$468,718
$131.94 P/Share
|
|
Feb 11
2019
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Grant, award, or other acquisition
|
Direct |
1,237
+5.09%
|
-
|
|
Feb 11
2019
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
7,541
+25.69%
|
-
|
|
Feb 11
2019
|
Jorge S. Mesquita Exec VP, WW Chair, Consumer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,577
-29.74%
|
$1,516,587
$131.94 P/Share
|
|
Feb 11
2019
|
Jorge S. Mesquita Exec VP, WW Chair, Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+6.67%
|
-
|
|
Feb 11
2019
|
Jorge S. Mesquita Exec VP, WW Chair, Consumer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,968
+31.95%
|
-
|
|
Feb 11
2019
|
Michael E Sneed EVP, Global Corp Aff & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,497
-6.61%
|
$458,107
$131.94 P/Share
|
|
Feb 11
2019
|
Michael E Sneed EVP, Global Corp Aff & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+2.21%
|
-
|
|
Feb 11
2019
|
Michael E Sneed EVP, Global Corp Aff & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,275
+12.34%
|
-
|
|
Feb 11
2019
|
Paulus Stoffels Vice Chair, Exec Committee |
SELL
Payment of exercise price or tax liability
|
Direct |
15,884
-6.42%
|
$2,080,804
$131.94 P/Share
|
|
Feb 11
2019
|
Paulus Stoffels Vice Chair, Exec Committee |
BUY
Grant, award, or other acquisition
|
Direct |
5,154
+2.04%
|
-
|
|
Feb 11
2019
|
Paulus Stoffels Vice Chair, Exec Committee |
BUY
Exercise of conversion of derivative security
|
Direct |
31,428
+11.48%
|
-
|
|
Feb 11
2019
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Payment of exercise price or tax liability
|
Direct |
6,236
-7.8%
|
$816,916
$131.94 P/Share
|
|
Feb 11
2019
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Grant, award, or other acquisition
|
Direct |
1,599
+1.96%
|
-
|
|
Feb 11
2019
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
9,748
+11.06%
|
-
|
|
Feb 11
2019
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
8,151
-5.76%
|
$1,067,781
$131.94 P/Share
|
|
Feb 11
2019
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,177
+1.51%
|
-
|
|
Feb 11
2019
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
13,273
+8.69%
|
-
|
|
Feb 11
2019
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,047
-8.87%
|
$530,157
$131.94 P/Share
|
|
Feb 11
2019
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,102
+2.36%
|
-
|
|
Feb 11
2019
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,722
+13.11%
|
-
|
|
Feb 11
2019
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,687
-8.01%
|
$1,006,997
$131.94 P/Share
|
|
Feb 11
2019
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,068
+2.11%
|
-
|
|
Feb 11
2019
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,609
+11.83%
|
-
|
|
Feb 11
2019
|
Joseph J Wolk Exec VP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
961
-6.46%
|
$125,891
$131.94 P/Share
|
|
Feb 11
2019
|
Joseph J Wolk Exec VP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
476
+3.1%
|
-
|
|
Feb 11
2019
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,903
+16.77%
|
-
|
|
Feb 11
2019
|
Ronald A Kapusta Controller, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
940
-5.03%
|
$123,140
$131.94 P/Share
|
|
Feb 11
2019
|
Ronald A Kapusta Controller, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
466
+2.43%
|
-
|
|
Feb 11
2019
|
Ronald A Kapusta Controller, CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,839
+13.47%
|
-
|
|
Feb 08
2019
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
2,798
-2.73%
|
$369,336
$132.0 P/Share
|
|
Feb 08
2019
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
9,049
+8.1%
|
-
|
|
Feb 08
2019
|
Alex Gorsky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,708
-3.32%
|
$1,545,456
$132.0 P/Share
|
|
Feb 08
2019
|
Alex Gorsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,579
+7.74%
|
-
|
|
Feb 08
2019
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Payment of exercise price or tax liability
|
Direct |
1,824
-11.33%
|
$240,768
$132.0 P/Share
|
|
Feb 08
2019
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
6,599
+29.08%
|
-
|
|
Feb 08
2019
|
Jorge S. Mesquita Exec VP, WW Chair, Consumer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,009
-13.57%
|
$397,188
$132.0 P/Share
|
|
Feb 08
2019
|
Jorge S. Mesquita Exec VP, WW Chair, Consumer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,787
+23.43%
|
-
|
|
Feb 08
2019
|
Michael E Sneed EVP, Global Corp Aff & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,827
-3.95%
|
$241,164
$132.0 P/Share
|
|
Feb 08
2019
|
Michael E Sneed EVP, Global Corp Aff & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,365
+12.1%
|
-
|
|
Feb 08
2019
|
Paulus Stoffels Vice Chair, Exec Committee |
SELL
Payment of exercise price or tax liability
|
Direct |
4,320
-2.01%
|
$570,240
$132.0 P/Share
|
|
Feb 08
2019
|
Paulus Stoffels Vice Chair, Exec Committee |
BUY
Exercise of conversion of derivative security
|
Direct |
12,571
+5.52%
|
-
|
|
Feb 08
2019
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Payment of exercise price or tax liability
|
Direct |
3,565
-4.94%
|
$470,580
$132.0 P/Share
|